TEGEDER, I
41  Ergebnisse:
Personensuche X
?
5

Dysregulation of lysophosphatidic acids in multiple scleros..:

Schmitz, K. ; Brunkhorst, R. ; de Bruin, N....
Acta Neuropathologica Communications.  5 (2017)  1 - p. , 2017
 
?
9

Contribution of genetic variants to pain susceptibility inP..:

Greenbaum, L. ; Tegeder, I. ; Barhum, Y....
European Journal of Pain.  16 (2012)  9 - p. 1243-1250 , 2012
 
?
10

Genetically Polymorphic OCT1: Another Piece in the Puzzle o..:

Tzvetkov, M V ; Saadatmand, A R ; Lötsch, J...
Clinical Pharmacology & Therapeutics.  90 (2011)  1 - p. 143-150 , 2011
 
?
11

Clinical genetics of functionally mild non-coding GTP cyclo..:

DOEHRING, A ; ANTONIADES, C ; CHANNON, K..
Mutation Research/Reviews in Mutation Research.  659 (2008)  3 - p. 195-201 , 2008
 
?
12

The Partial 5-Hydroxytryptamine1A Receptor Agonist Buspiron..:

Oertel, B G ; Schneider, A ; Rohrbacher, M...
Clinical Pharmacology & Therapeutics.  81 (2007)  1 - p. 59-68 , 2007
 
?
13

Accumulation of phosphorylated IκBα and activated IKK in no..:

Politi, C. ; Del Turco, D. ; Sie, J. M....
Neuropathology and Applied Neurobiology.  34 (2007)  3 - p. 357-365 , 2007
 
?
15

Pathophysiology and treatment of pain in joint disease☆:

SCHAIBLE, H ; SCHMELZ, M ; TEGEDER, I
Advanced Drug Delivery Reviews.  58 (2006)  2 - p. 323-342 , 2006
 
1-15